FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products | Foley & Lardner LLP

On October 23, the U.S. Food and Drug Administration (FDA) issued draft guidance, Communication from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses...

Related Keywords

,Drug Administration ,Unapproved Uses ,Cleared Medical Products ,Standard Requiring Communication ,Scientifically Sound ,Provide Clinically Relevant ,